The University of Arkansas for Medical Sciences (UAMS) and the ALS Association have opened a new multidisciplinary clinic at ...
A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...
Jacksonville Journal-Courier on MSN

Non-profit holding Walk to Defeat ALS in Springfield

The ALS Association's Walk to Defeat ALS in Springfield will raise money for research into the neurodegenerative disease.
The University of Arkansas for Medical Sciences (UAMS) and the ALS Association recently opened the first Northwest Arkansas ...
In a now-completed clinical trial, the stem cell therapy Neuronata-R was found to benefit ALS patients with slower disease ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
The Chosun Ilbo on MSN

ALS YouTuber Philseungju Dies at 32

YouTuber ‘Philseungju’ Kang Seung-joo, who shared his battle with Lou Gehrig’s disease, passed away at the young age of 32.
Key points New evidence has led to a change in the way that some patients with amyotrophic lateral sclerosis (ALS) are classified and treated. Based on the findings of a landmark trial,[1][1] the drug ...